阻滞剂-话题@MedSci

#阻滞剂#

205篇内容 | 4058人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2085691, encodeId=4e062085691e7, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=Bloxiverz获准用于逆转神经肌肉阻滞剂效应, objectType=article, longId=20157, objectId=673c2015e76, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=673c2015e76, replyNumber=0, likeNumber=85, createdTime=2013-12-16, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=673c2015e76, moduleTitle=Bloxiverz获准用于逆转神经肌肉阻滞剂效应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=673c2015e76)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085697, encodeId=3202208569e68, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=黄峻：JNC8不能否认β受体阻滞剂的“中国特色”, objectType=article, longId=28725, objectId=acd428e2528, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=acd428e2528, replyNumber=0, likeNumber=80, createdTime=2014-01-23, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=acd428e2528, moduleTitle=黄峻：JNC8不能否认β受体阻滞剂的“中国特色”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=acd428e2528)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085695, encodeId=a1f2208569517, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=JAMA Intern Med：行非心脏手术的缺血性心脏病患者应用β受体阻滞剂的疗效, objectType=article, longId=27315, objectId=c61a2e315da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c61a2e315da, replyNumber=0, likeNumber=72, createdTime=2014-02-16, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c61a2e315da, moduleTitle=JAMA Intern Med：行非心脏手术的缺血性心脏病患者应用β受体阻滞剂的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c61a2e315da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085694, encodeId=4d83208569479, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=JAMA：感染性休克患者应用β阻滞剂可达目标心率且不增加不良结局, objectType=article, longId=25519, objectId=8d4625519d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d4625519d1, replyNumber=0, likeNumber=78, createdTime=2014-02-22, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d4625519d1, moduleTitle=JAMA：感染性休克患者应用β阻滞剂可达目标心率且不增加不良结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d4625519d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085696, encodeId=84cb208569654, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=Chest：荟萃分析显示哮喘患者可有选择地使用β受体阻滞剂, objectType=article, longId=28410, objectId=52282841047, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52282841047, replyNumber=0, likeNumber=74, createdTime=2013-12-22, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52282841047, moduleTitle=Chest：荟萃分析显示哮喘患者可有选择地使用β受体阻滞剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52282841047)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085689, encodeId=4c492085689bc, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=ACE抑制剂与β受体阻滞剂或许可预防化疗导致的心脏毒性, objectType=article, longId=17412, objectId=8f1e1e412de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f1e1e412de, replyNumber=0, likeNumber=68, createdTime=2013-04-17, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f1e1e412de, moduleTitle=ACE抑制剂与β受体阻滞剂或许可预防化疗导致的心脏毒性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f1e1e412de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085687, encodeId=848e208568e88, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=β受体阻滞剂不影响慢性肾病死亡率, objectType=article, longId=13153, objectId=cda1131536b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cda1131536b, replyNumber=0, likeNumber=75, createdTime=2013-11-07, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cda1131536b, moduleTitle=β受体阻滞剂不影响慢性肾病死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cda1131536b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085692, encodeId=c0be2085692f1, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=2013 β受体阻滞剂在高血压应用中的专家指导建议, objectType=article, longId=20773, objectId=ee5020e7340, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee5020e7340, replyNumber=0, likeNumber=69, createdTime=2014-06-06, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee5020e7340, moduleTitle=2013 β受体阻滞剂在高血压应用中的专家指导建议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee5020e7340)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085690, encodeId=3c3d208569063, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=JAMA：非心脏手术围手术期使用β-受体阻滞剂或可降低患者死亡率, objectType=article, longId=17769, objectId=1b141e76998, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b141e76998, replyNumber=0, likeNumber=79, createdTime=2013-11-07, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b141e76998, moduleTitle=JAMA：非心脏手术围手术期使用β-受体阻滞剂或可降低患者死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b141e76998)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085688, encodeId=b64c208568895, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=对于高血压患者β受体阻滞剂可减少阿尔茨海默型脑损伤, objectType=article, longId=14661, objectId=b1d51466163, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1d51466163, replyNumber=0, likeNumber=59, createdTime=2013-03-23, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1d51466163, moduleTitle=对于高血压患者β受体阻滞剂可减少阿尔茨海默型脑损伤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1d51466163)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085686, encodeId=be1f2085686ef, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=欧盟评估多奈哌齐的神经阻滞剂恶性综合征风险, objectType=article, longId=11936, objectId=597e119361b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=597e119361b, replyNumber=0, likeNumber=97, createdTime=2013-08-03, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=597e119361b, moduleTitle=欧盟评估多奈哌齐的神经阻滞剂恶性综合征风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=597e119361b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085677, encodeId=e8d620856e7c1, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=If通道阻滞剂或具心衰预防额外益处, objectType=article, longId=5365, objectId=fe1a536577, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe1a536577, replyNumber=0, likeNumber=67, createdTime=2012-04-23, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe1a536577, moduleTitle=If通道阻滞剂或具心衰预防额外益处, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe1a536577)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085684, encodeId=65d02085684e2, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=JAMA：β-阻滞剂不能改善冠脉疾病患者的临床转归, objectType=article, longId=10327, objectId=17ce1032e46, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17ce1032e46, replyNumber=0, likeNumber=83, createdTime=2013-03-23, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17ce1032e46, moduleTitle=JAMA：β-阻滞剂不能改善冠脉疾病患者的临床转归, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17ce1032e46)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085685, encodeId=0f34208568524, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=SLEEP：褪黑素可改善高血压患者应用β受体阻滞剂相关失眠, objectType=article, longId=10972, objectId=f43a109e2b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f43a109e2b3, replyNumber=0, likeNumber=77, createdTime=2013-10-13, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f43a109e2b3, moduleTitle=SLEEP：褪黑素可改善高血压患者应用β受体阻滞剂相关失眠, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f43a109e2b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085679, encodeId=e59720856e92c, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=从PURE研究谈β受体阻滞剂对社区冠心病的二级预防, objectType=article, longId=5919, objectId=fa5d5919df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa5d5919df, replyNumber=0, likeNumber=65, createdTime=2012-12-18, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa5d5919df, moduleTitle=从PURE研究谈β受体阻滞剂对社区冠心病的二级预防, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa5d5919df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085680, encodeId=46dd2085680a5, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=Cancer: β受体阻滞剂并不降低结直肠癌风险, objectType=article, longId=6180, objectId=fee36180e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fee36180e0, replyNumber=0, likeNumber=76, createdTime=2013-03-05, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fee36180e0, moduleTitle=Cancer: β受体阻滞剂并不降低结直肠癌风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fee36180e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085681, encodeId=1dce2085681e0, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=β阻滞剂预防失败者静脉曲张再出血风险翻倍, objectType=article, longId=6211, objectId=7ff0621125, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ff0621125, replyNumber=0, likeNumber=58, createdTime=2013-04-30, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ff0621125, moduleTitle=β阻滞剂预防失败者静脉曲张再出血风险翻倍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ff0621125)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085682, encodeId=a3832085682ee, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=柯元南:澄清观念,用好β受体阻滞剂, objectType=article, longId=7160, objectId=52d5e16003, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52d5e16003, replyNumber=0, likeNumber=84, createdTime=2012-10-18, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52d5e16003, moduleTitle=柯元南:澄清观念,用好β受体阻滞剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52d5e16003)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085683, encodeId=7dc020856834d, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=β受体阻滞剂有待深入研究, objectType=article, longId=7280, objectId=d6a3e280ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6a3e280ee, replyNumber=0, likeNumber=86, createdTime=2013-02-09, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6a3e280ee, moduleTitle=β受体阻滞剂有待深入研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6a3e280ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085678, encodeId=d8b020856e808, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=儿童患者，如何选择β受体阻滞剂, objectType=article, longId=5918, objectId=e37c59183f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e37c59183f, replyNumber=0, likeNumber=92, createdTime=2013-02-20, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e37c59183f, moduleTitle=儿童患者，如何选择β受体阻滞剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e37c59183f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

阻滞剂

2020-05-29

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

Bloxiverz获准用于逆转神经肌肉阻滞剂效应

2013-12-16

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

黄峻：JNC8不能否认β受体阻滞剂的“中国特色”

2014-01-23

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

JAMA Intern Med：行非心脏手术的缺血性心脏病患者应用β受体阻滞剂的疗效

2014-02-16

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

JAMA：感染性休克患者应用β阻滞剂可达目标心率且不增加不良结局

2014-02-22

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

Chest：荟萃分析显示哮喘患者可有选择地使用β受体阻滞剂

2013-12-22

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

ACE抑制剂与β受体阻滞剂或许可预防化疗导致的心脏毒性

2013-04-17

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

β受体阻滞剂不影响慢性肾病死亡率

2013-11-07

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

2013 β受体阻滞剂在高血压应用中的专家指导建议

2014-06-06

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

JAMA：非心脏手术围手术期使用β-受体阻滞剂或可降低患者死亡率

2013-11-07

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

对于高血压患者β受体阻滞剂可减少阿尔茨海默型脑损伤

2013-03-23

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

欧盟评估多奈哌齐的神经阻滞剂恶性综合征风险

2013-08-03

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

If通道阻滞剂或具心衰预防额外益处

2012-04-23

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

JAMA：β-阻滞剂不能改善冠脉疾病患者的临床转归

2013-03-23

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

SLEEP：褪黑素可改善高血压患者应用β受体阻滞剂相关失眠

2013-10-13

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

从PURE研究谈β受体阻滞剂对社区冠心病的二级预防

2012-12-18

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

Cancer: β受体阻滞剂并不降低结直肠癌风险

2013-03-05

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

β阻滞剂预防失败者静脉曲张再出血风险翻倍

2013-04-30

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

柯元南:澄清观念,用好β受体阻滞剂

2012-10-18

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

β受体阻滞剂有待深入研究

2013-02-09

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

儿童患者，如何选择β受体阻滞剂

2013-02-20

科室
- - 订阅+
  - 更多科室
工具
服务